Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization

Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization

Background: Radioembolization (RE) with yttrium-90 (<sup>90</sup>Y) resin microspheres yields heterogeneous response rates in with primary or secondary liver cancer. Radiation-induced liver disease (RILD) is a potentially life-threatening complication with higher prevalence in cirrhotics...

Full description

Bibliographic Details
Main Authors: Max Seidensticker, Matthias Philipp Fabritius, Jannik Beller, Ricarda Seidensticker, Andrei Todica, Harun Ilhan, Maciej Pech, Constanze Heinze, Maciej Powerski, Robert Damm, Alexander Weiss, Johannes Rueckel, Jazan Omari, Holger Amthauer, Jens Ricke
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
radioembolization
radiation induced liver disease
RILD
prophylaxis
Online Access:https://www.mdpi.com/2072-6694/13/9/1992

Internet

https://www.mdpi.com/2072-6694/13/9/1992

Similar Items